Business Wire6d
Boehringer Ingelheim India and EMRI Green Health Services a GVK Enterprise Sign MoU to Transform Pre-hospital Stroke Care in India
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing ...
manilatimes7d
GREATER GOOD CHARITIES TEAMS UP WITH BOEHRINGER INGELHEIM FOR THE 10th ANNUAL SHELTER BOWL TO RAISE FUNDS FOR PETS IN NEED
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and ...
Morningstar7d
GREATER GOOD CHARITIES TEAMS UP WITH BOEHRINGER INGELHEIM FOR THE 10th ANNUAL SHELTER BOWL TO RAISE FUNDS FOR PETS IN NEED
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers ...
pharmaphorum5d
Sanofi to be No.1 in consumer health via Boehringer multi-billion swap
Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for its animal health business Merial – the latest in a trend for multi-billion swaps in big pharma. The deal ...
Finanznachrichten27d
Boehringer Ingelheim Limited: Boehringer provides update on iclepertin Phase III program in schizophrenia
13 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in Research and Development, the company focuses on developing ...
The Week5d
Boehringer Ingelheim India and EMRI Green Health Services a GVK Enterprise Sign MoU to Transform Pre-hospital Stroke Care in India
About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company ...
Business Insider27d
Boehringer provides update on iclepertin Phase III program in schizophrenia
13 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on ...
Wall Street Journal1d
Elanco Animal Health Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Wall Street Journal1d
Phibro Animal Health Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Pharmaceutical Technology23d
BI-765845 by Boehringer Ingelheim International for Myocardial Infarction: Likelihood of Approval
BI-765845 is under clinical development by Boehringer Ingelheim International and currently in Phase ... It offers an array of products including human diseases, animal health care products, and ...
CNN25d
With bird flu cases rising, certain kinds of pet food may be risky for animals – and people
This should prevent meat or eggs from infected birds from entering the food supply, according to the USDA’s Animal and Plant Health Inspection Service. Pet foods are regulated at both the ...